{
    "2018-10-25": [
        [
            {
                "time": "",
                "original_text": "机构评级精选：5G时代受益显著 中新赛克评级获机构上调",
                "features": {
                    "keywords": [
                        "5G",
                        "时代",
                        "受益",
                        "显著",
                        "中新赛克",
                        "评级",
                        "上调"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "通信"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国金晨报精选：推荐健帆生物/Q4限售股解禁/申通快递/天润乳业",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "Q4",
                        "限售股",
                        "解禁",
                        "申通快递",
                        "天润乳业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "物流",
                        "食品饮料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【健帆生物（300529）】三季度业绩略超预期，实现加速增长",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529",
                        "三季度",
                        "业绩",
                        "超预期",
                        "加速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药丨周小刚】健帆生物(300529)：预计核心产品销量增长超50%，业绩大超市场预期",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529",
                        "核心产品",
                        "销量增长",
                        "50%",
                        "业绩",
                        "超市场预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}